含有多GR的聚合物与阿尔茨海默病的病理学和临床特征有关
Huong T Phuong1,2, Rodrigo F Tomas1,2, Cemal Akmese1
1Center for NeuroGenetics, College of Medicine, University of Florida, Gainesville, USA.
Acta neuropathologica
|November 8, 2025
概括
聚合物甘氨酸-氨酸 (polyGR+) 聚合物是一种新型蛋白病,在60%的阿尔茨海默氏症患者中发现.
科学领域:
- 神经科学是一个神经科学.
- 神经病理学神经病理学
- 分子生物学分子生物学
背景情况:
- 阿尔茨海默病 (AD) 是最常见的痴呆症,但其分子基础仍然不清楚.
- 含有多聚甘氨酸和氨酸 (polyGR+) 的聚合物代表了AD大脑中新发现的蛋白质病变.
- 聚GR+聚合物与AD神经病理变化 (ADNC) 和临床结果的关联需要全面调查.
研究的目的:
- 调查聚GR+聚合物的患病率和与AD神经病理变化 (ADNC) 的关联.
- 探索聚GR+聚合物与临床特征之间的关系,包括发病年龄和存活率.
- 检查聚GR+聚合物与其他神经退行性病理和危险因素的同时出现.
主要方法:
- 从三个AD队列和对照组中对死后大脑中的多GR+聚合物的分析.
- 评估polyGR+聚合物形态和同位点与缩性神经炎标志物的评估.
- 粉样β (Aβ) 斑块和酸化 (pTau) 的量化与多GR+水平相关.
- 调查多GR+聚合物与边缘主导性与年龄相关的TDP-43脑病变神经病理变化 (LATE-NC) 和莱维体病理 (LBP) 的同时发生.
- 河马的polyGR+水平与中风和高血压等临床因素之间的相关性分析.
- 使用SH-SY5Y细胞进行体外研究,以评估氧化应激对聚GR+蛋白生产和pTau积累的影响,与CASP8 GGGAGA重复扩张有关.
主要成果:
- 在大约60%的AD大脑中检测到PolyGR+聚合物,但在对照组中没有.
- 聚GR+聚合物的特定亚型与阿兹海默症患者早期发病和减少存活率相关.
- 较高的polyGR+聚合物水平与海马体内Aβ斑块和pTau的增加有关.
- 发现PolyGR+聚合物与LATE-NC和Lewy体病理学共存.
- 在患有中风或高血压的晚期阿尔茨海默病例中观察到海马多聚GR+水平升高.
- 氧化应激诱导了通过CASP8 GGGAGA重复扩张和增加pTau积累在体外的polyGR+蛋白质的产生.
结论:
- 聚GR+聚合物是阿尔茨海默病尸检大脑中常见且未经研究的蛋白质病变.
- 多GR蛋白质病症与AD神经病理变化 (ADNC) 和临床结果有显著的关联.
- 这些发现凸显了polyGR+聚合物作为阿尔茨海默病潜在的新疗法标.
相关概念视频
01:26Alzheimer's Disease: Overview
1.6K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.6K
03:03Amyloid Fibrils
11.5K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
11.5K
03:03Amyloid Fibrils
6.3K
6.3K
01:30Dementia
503
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
503
01:22Alzheimer's Disease: Treatment
782
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
782